GI Illness

<i>C difficile</i> Risk Higher With Stoma Reversal vs Colectomy

C difficile Risk Higher With Stoma Reversal vs Colectomy

Given the impact of postoperative Clostridium difficile infection, a heightened sense of suspicion should be given to symptomatic patients after stoma reversal.

<i>Clostridium difficile</i> Infection in the Intensive Care Setting

Clostridium difficile Infection in the Intensive Care Setting

By

It is important to understand the relative severity of CDI in patients in the ICU because it effects treatment decisions. However, primary prevention remains a vitally important strategy to limit morbidity and mortality related to CDI in this vulnerable patient population.

FDA Issues Mandatory Recall for Food Products Containing Powdered Kratom

FDA Issues Mandatory Recall for Food Products Containing Powdered Kratom

By

The agency took this action after Triangle Pharmanaturals LLC failed to cooperate with the FDA's request to conduct a voluntary recall.

1980 to 2014 Saw Decrease in US Mortality From Infectious Diseases

1980 to 2014 Saw Decrease in US Mortality From Infectious Diseases

There were declines in mortality from most categories of infectious diseases, with large differences among US counties. However, over this time there was an increase in mortality for diarrheal diseases.

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

Firvanq Availability Replaces Need for Compounded Oral Vancomycin Solution

By

FIRVANQ is commercially available in 25 and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes.

<i>H pylori</i> Treatment Tied to Lower Metachronous Gastric Cancer Risk

H pylori Treatment Tied to Lower Metachronous Gastric Cancer Risk

Helicobacter pylori treatment is associated with a reduced rate of metachronous gastric cancer.

Recurrent Salmonella enterica Typhimurium infection disables host protection against intestinal inflammation [PreClinical]

Increased turnover of intestinal alkaline phosphatase (IAP), related to increased endogenous neuraminidase activity among duodenal enterocytes, was found to be associated with inflammatory bowel disease.

FDA: Vancomycin Liquid Oral Treatment Approved for <i>C diff</i>-Associated Diarrhea

FDA: Vancomycin Liquid Oral Treatment Approved for C diff-Associated Diarrhea

By

Vancomycin is the first liquid oral treatment for C diff-associated diarrhea.

<i>Helicobacter pylori</i> Infection Linked to Gallbladder Diseases

Helicobacter pylori Infection Linked to Gallbladder Diseases

Study aimed to clarify the prevalence of gallbladder diseases, and factors related to gallbladder diseases, and relationships between H pylori infection, gallstones, cholecystitis, and cholecystic polypus.

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

Delaying Rotavirus Vaccination Until Discharge Leads to Missed Opportunities

By

Study found that many hospitalized infants did not receive rotavirus vaccination before discharge and were no longer age-eligible for vaccination after discharge from the hospital.

Raw Flour Linked to <i>Escherichia coli</i>

Raw Flour Linked to Escherichia coli

Raw flour has been linked to E coli infections in 24 states.

IDSA Updates Infectious Diarrhea Guidelines

IDSA Updates Infectious Diarrhea Guidelines

By

The Infectious Diseases Society of America updated its guidelines for the management of acute or persistent infectious diarrhea.

Efficacy of <i>Goshuyuto</i>/Rabeprazole for Refractory <i>H pylori</i>

Efficacy of Goshuyuto/Rabeprazole for Refractory H pylori

Refractory Helicobacter pylori infection can be successfully treated with goshuyuto and rabeprazole.

Better Detection and Treatment Needed for <i>H pylori</i> Infections in Children

Better Detection and Treatment Needed for H pylori Infections in Children

By

In recent years, a link between childhood Helicobacter pylori and gastric cancer in adulthood has elevated the need to detect and treat H pylori in asymptomatic children.

Bezlotoxumab Reduces 30-Day Hospital Readmissions for <I>C difficile</I> Infection

Bezlotoxumab Reduces 30-Day Hospital Readmissions for C difficile Infection

By

Bezlotoxumab, given with antibacterials for Clostridium difficile, could be effective as a preventive treatment for C difficile infection.

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Implementation of rotavirus vaccination correlated with a reduction in acute gastroenteritis related hospitalization rates among children.

CDC Issues Advisory on the Rise of Cyclosporiasis

CDC Issues Advisory on the Rise of Cyclosporiasis

By

The CDC Health Alert Network has issued an advisory regarding an increase in cases of the intestinal illness cyclosporiasis.

Biotherapeutics for the Prevention of <i>Clostridium difficile</i> Infection

Biotherapeutics for the Prevention of Clostridium difficile Infection

Experts review biotherapeutics for the prevention of C difficile infection, including probiotics, fecal microbiota transplantation, and nontoxigenic C difficile.

Efficacy of Bismuth-Based Quad Tx vs Levofloxacin Triple Tx for <i>H pylori</i>

Efficacy of Bismuth-Based Quad Tx vs Levofloxacin Triple Tx for H pylori

The addition of bismuth subcitrate to levofloxacin-based triple therapy is not associated with increased effectiveness in patients with Helicobacter pylori infection.

Multiply Recurrent <I>C difficile</I> Infection Rate 4 Times Higher Than CDI

Multiply Recurrent C difficile Infection Rate 4 Times Higher Than CDI

By

The rate of multiply recurrent Clostridium difficile (mrCDI) was found to be more than 4 times higher than that of original CDI, with important implications for treatment decisions.

<I>Clostridium difficile</i> Infection Rates Increase in Patients With Cancer

Clostridium difficile Infection Rates Increase in Patients With Cancer

By

Results of a recent study have shown that infection with Clostridium difficile is increasing in frequency and negatively affects clinical and care outcomes in patients with cancer.

New Method Gauges Persistence of Donor Microbes After Fecal Transplant

New Method Gauges Persistence of Donor Microbes After Fecal Transplant

Therapeutic donor microbes can remain for months or years in patients who've undergone fecal microbiota transplantation.

Liver Cancer Mortality Rates Have Doubled Since Mid-1980s

Liver Cancer Mortality Rates Have Doubled Since Mid-1980s

Liver cancer has become the fastest growing cause of cancer deaths in the Unites States.

<i>C difficile</i> Treatment and Prevention: Novel Antibiotics and Immunologic Therapies

C difficile Treatment and Prevention: Novel Antibiotics and Immunologic Therapies

Experts review novel antibiotic therapies that may limit the impact on the gut microbiome, as well as passive immunization products that may bolster the immune response to C difficile toxins and possibly reduce the frequency of toxigenic strains.

Case of <i>Vibrio vulnificus</i> Septic Shock Leading to Death After New Tattoo

Case of Vibrio vulnificus Septic Shock Leading to Death After New Tattoo

By

A patient who recently acquired a new tattoo developed Vibrio vulnificus septic shock after swimming in seawater, leading to death.

Ridinilazole Beats Standard of Care in Phase 2 <i>C difficile</i> Study

Ridinilazole Beats Standard of Care in Phase 2 C difficile Study

By

Recurrent Clostridium difficile infection is associated with a significant economic and mortality burden, but new treatment shows promise.

Oral Prophylactic Therapy Designated Breakthrough Therapy for CDI Prevention

Oral Prophylactic Therapy Designated Breakthrough Therapy for CDI Prevention

By

The FDA granted Breakthrough Therapy designation to Synthetic Biologics' ribaxamase SYN-004 for Clostridium difficile infection prevention.

Intestinal Dysbiosis May Link ME/CFS With GI and Neurological Disturbances

Intestinal Dysbiosis May Link ME/CFS With GI and Neurological Disturbances

Findings indicate that dysbiotic features that are uniquely ME/CFS-associated may be masked by disturbances arising from the high prevalence of IBS co-morbidity in ME/CFS.

Community-Based Risk Factors for <i>C difficile</i> Infection in Children

Community-Based Risk Factors for C difficile Infection in Children

By

Community-associated C difficile infection in children was linked to the combination of commonly used antibiotics and exposure to the bacterium in the home and outpatient healthcare settings.

CDC Issues New Recommendations for Treating <i>Shigella</i> Infection

CDC Issues New Recommendations for Treating Shigella Infection

By

The CDC has issued an alert regarding new recommendations for the treatment of Shigella infection.

Sign Up for Free e-newsletters